tradingkey.logo

Merit Medical Systems Inc

MMSI

84.540USD

+0.590+0.70%
Close 07/17, 16:00ETQuotes delayed by 15 min
4.99BMarket Cap
40.85P/E TTM

Merit Medical Systems Inc

84.540

+0.590+0.70%
More Details of Merit Medical Systems Inc Company
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Company Info
Ticker SymbolMMSI
Company nameMerit Medical Systems Inc
IPO dateSep 16, 1954
Founded at1987
CEO- -
Number of employees7400
Security typeOrdinary Share
Fiscal year-endSep 16
Address1600 West Merit Park Way
CitySOUTH JORDAN
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code84095
Phone18012531600
Websitehttps://www.merit.com/
Ticker SymbolMMSI
IPO dateSep 16, 1954
Founded at1987
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.11M
-0.93%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
Mr. Michel J. Voigt
Mr. Michel J. Voigt
Chief Human Resources Officer
Chief Human Resources Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.11M
-0.93%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
137.28M
38.63%
Cardiac Intervention
99.74M
28.07%
OEM
53.75M
15.13%
Custom Procedural Solutions
47.94M
13.49%
Endoscopy devices
16.64M
4.68%
By RegionUSD
Name
Revenue
Proportion
United States
213.56M
60.10%
International
141.79M
39.90%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
137.28M
38.63%
Cardiac Intervention
99.74M
28.07%
OEM
53.75M
15.13%
Custom Procedural Solutions
47.94M
13.49%
Endoscopy devices
16.64M
4.68%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
11.10%
Conestoga Capital Advisors, LLC
3.83%
State Street Global Advisors (US)
3.71%
Fuller & Thaler Asset Management Inc.
2.99%
Other
64.53%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
11.10%
Conestoga Capital Advisors, LLC
3.83%
State Street Global Advisors (US)
3.71%
Fuller & Thaler Asset Management Inc.
2.99%
Other
64.53%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
47.16%
Investment Advisor
45.45%
Hedge Fund
8.30%
Research Firm
3.48%
Individual Investor
2.28%
Bank and Trust
1.98%
Pension Fund
1.65%
Sovereign Wealth Fund
1.23%
Insurance Company
0.08%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
747
65.96M
111.61%
-316.93K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
2023Q1
600
56.86M
99.01%
-1.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.18M
13.84%
-174.56K
-2.09%
Mar 31, 2025
The Vanguard Group, Inc.
6.56M
11.1%
-77.00K
-1.16%
Mar 31, 2025
Conestoga Capital Advisors, LLC
2.27M
3.83%
-24.73K
-1.08%
Mar 31, 2025
State Street Global Advisors (US)
2.19M
3.71%
-99.26K
-4.33%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.77M
2.99%
+133.47K
+8.17%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.47M
2.49%
+206.25K
+16.29%
Mar 31, 2025
Macquarie Investment Management
1.45M
2.46%
+2.73K
+0.19%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.40M
2.37%
+40.56K
+2.99%
Mar 31, 2025
Invesco Advisers, Inc.
1.35M
2.28%
+47.94K
+3.69%
Mar 31, 2025
Maverick Capital, Ltd.
1.27M
2.15%
+1.27M
--
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.96%
Invesco Dorsey Wright Healthcare Momentum ETF
3.18%
AAM Sawgrass US Small Cap Quality Growth ETF
2.1%
First Trust Indxx Medical Devices ETF
1.92%
SPDR S&P Health Care Equipment ETF
1.79%
Invesco S&P SmallCap Momentum ETF
1.37%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.11%
iShares MSCI USA Small-Cap Min Vol Factor ETF
1.06%
ETC 6 Meridian Small Cap Equity ETF
1.05%
Thrivent Small-Mid Cap ESG ETF
1.05%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.96%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion3.18%
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion2.1%
First Trust Indxx Medical Devices ETF
Proportion1.92%
SPDR S&P Health Care Equipment ETF
Proportion1.79%
Invesco S&P SmallCap Momentum ETF
Proportion1.37%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion1.11%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion1.06%
ETC 6 Meridian Small Cap Equity ETF
Proportion1.05%
Thrivent Small-Mid Cap ESG ETF
Proportion1.05%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI